Table 3.
Summary of the independent association results from the stratified analysis
Gene | Alleles | OR* | P value* | Conditioned P value | Phenotype | OR† | Intracase P value† |
HLA-DQA1 | DQA1*02:01 | 0.54 | 5.23E-51 | NA‡ | lcSSc | 0.71 | 2.08E-08 |
HLA-DQA1 | DQA1*05:01 | 1.49 | 1.16E-30 | 1.59E-11 | dcSSc | 1.30 | 1.76E-11 |
HLA-DRB1 | DRB1*08:01 | 3.18 | 9.73E-57 | 4.00E-64 | ACA | 2.17 | 1.42E-10 |
HLA-DRB1 | DRB1*07:01 | 0.36 | 1.17E-63 | 1.84E-45 | ACA | 0.42 | 3.85E-27 |
HLA-DPA1 | DPA1*02:01 | 1.87 | 7.91E-43 | 2.93E-19 | ATA | 2.41 | 1.09E-40 |
HLA-DQB1 | DQB1*03:01 | 1.86 | 7.11E-47 | 7.00E-19 | ATA | 1.67 | 1.73E-22 |
*Association effect and p value compared with the control group.
†Association effect and p value in the intracase comparisons (dcSSc with lcSSc and ATA with ACA).
‡Not available as it was the most significant allele in the sequential conditional model.
ACA, anticentromere; ATA, antitopoisomerase; dcSSc, diffuse cutaneous systemic sclerosis; lcSSc, limited cutaneous systemic sclerosis.